Medicine Pharmacy Nutrition

Healthcare News and Reviews

  • Welcome
  • News

Active Polyarticular JIA

No Image

Pfizer’s Xeljanz (tofacitinib citrate) Receives EC’s Approval for the Treatment of Active Polyarticular JIA & Juvenile PsA

August 23, 2021 Auto Bot 0

Shots: The approval is based on a P-III study which includes 2 phases i.e., run-in & withdrawal phase evaluating efficacy & safety of tofacitinib (5mg […]

Nutrition

A Plant-Based Workplace Wellness Program Put to the Test

Auto Bot / August 18, 2022
Nutrition

What Is the Bro Diet, and Is It Healthy?

Auto Bot / August 17, 2022

Healthcare Communications Association

Get Well Launches Monkeypox Digital Care Management Plan

AutoBot / August 18, 2022
Healthcare Communications Association

Pharma giants slam Medicare drug price negotiation

AutoBot / August 18, 2022
Healthcare Communications Association

White House: Updated boosters for adults, teens expected in a few weeks

AutoBot / August 18, 2022
Healthcare Communications Association

University of Maryland reports first presumptive monkeypox case

AutoBot / August 18, 2022
Healthcare Communications Association

I ran a mental health clinic in Uvalde. Now I support a new approach

AutoBot / August 18, 2022
Healthcare Communications Association

Mental Health Parity at a Crossroads

AutoBot / August 18, 2022
Healthcare Communications Association

COVID-19 booster campaign to start on 5 September, NHS England says

AutoBot / August 18, 2022
Healthcare Communications Association

The new Teeny Tiny Stevies song ‘I got you’

AutoBot / August 18, 2022
Healthcare Communications Association

Some Rural Hospitals Are in Such Bad Shape, Local Governments Are Practically Giving Them Away

AutoBot / August 18, 2022
Healthcare Communications Association

Her Brother Landed in a Nursing Home. She Was Sued Over His Bill.

AutoBot / August 18, 2022
Healthcare Communications Association

Sleepless Nights Over Her Children’s Future as Debts Pile Up

AutoBot / August 18, 2022
Healthcare Communications Association

Beyond the Byline: Venture capital firms lure health system CEOs

AutoBot / August 18, 2022
Healthcare Communications Association

Cardiac Science – Cardiac Surgery Packages & Cost Guide

AutoBot / August 18, 2022
Healthcare Communications Association

How real-time benefit tools deliver meaningful savings

AutoBot / August 18, 2022
Healthcare Communications Association

Preventative Health Programs Need to Address 3 Key Components

AutoBot / August 18, 2022
Healthcare Communications Association

Half of Texas school districts don’t offer mental health services: report

AutoBot / August 18, 2022
Healthcare Communications Association

Health Care — Changes coming to the CDC after missteps

AutoBot / August 17, 2022
Healthcare Communications Association

Walmart, CVS and Walgreens ordered to pay $650 million to Ohio counties for opioid crisis

AutoBot / August 17, 2022
Healthcare Communications Association

With workplace violence on the rise, some health systems are hiring experts to address it

AutoBot / August 17, 2022
Healthcare Communications Association

Hearing experts applaud FDA approval of over the counter hearing aids

AutoBot / August 17, 2022

Nutrition

A Plant-Based Workplace Wellness Program Put to the Test

Auto Bot / August 18, 2022
Nutrition

What Is the Bro Diet, and Is It Healthy?

Auto Bot / August 17, 2022

Healthcare Communications Association

Get Well Launches Monkeypox Digital Care Management Plan

AutoBot / August 18, 2022
Healthcare Communications Association

Pharma giants slam Medicare drug price negotiation

AutoBot / August 18, 2022
Healthcare Communications Association

White House: Updated boosters for adults, teens expected in a few weeks

AutoBot / August 18, 2022
Healthcare Communications Association

University of Maryland reports first presumptive monkeypox case

AutoBot / August 18, 2022
Healthcare Communications Association

I ran a mental health clinic in Uvalde. Now I support a new approach

AutoBot / August 18, 2022
Healthcare Communications Association

Mental Health Parity at a Crossroads

AutoBot / August 18, 2022
Healthcare Communications Association

COVID-19 booster campaign to start on 5 September, NHS England says

AutoBot / August 18, 2022
Healthcare Communications Association

The new Teeny Tiny Stevies song ‘I got you’

AutoBot / August 18, 2022
Healthcare Communications Association

Some Rural Hospitals Are in Such Bad Shape, Local Governments Are Practically Giving Them Away

AutoBot / August 18, 2022
Healthcare Communications Association

Her Brother Landed in a Nursing Home. She Was Sued Over His Bill.

AutoBot / August 18, 2022
Healthcare Communications Association

Sleepless Nights Over Her Children’s Future as Debts Pile Up

AutoBot / August 18, 2022
Healthcare Communications Association

Beyond the Byline: Venture capital firms lure health system CEOs

AutoBot / August 18, 2022
Healthcare Communications Association

Cardiac Science – Cardiac Surgery Packages & Cost Guide

AutoBot / August 18, 2022
Healthcare Communications Association

How real-time benefit tools deliver meaningful savings

AutoBot / August 18, 2022
Healthcare Communications Association

Preventative Health Programs Need to Address 3 Key Components

AutoBot / August 18, 2022
Healthcare Communications Association

Half of Texas school districts don’t offer mental health services: report

AutoBot / August 18, 2022
Healthcare Communications Association

Health Care — Changes coming to the CDC after missteps

AutoBot / August 17, 2022
Healthcare Communications Association

Walmart, CVS and Walgreens ordered to pay $650 million to Ohio counties for opioid crisis

AutoBot / August 17, 2022
Healthcare Communications Association

With workplace violence on the rise, some health systems are hiring experts to address it

AutoBot / August 17, 2022
Healthcare Communications Association

Hearing experts applaud FDA approval of over the counter hearing aids

AutoBot / August 17, 2022

News Pharmacy

3 ways pharma can prep for Biden’s sweeping drug pricing policies

AutoBot / August 18, 2022
News Pharmacy

CSL Vifor’s Tavneos (avacopan) Receives NICE Recommendation for the Treatment of Anca-Associated Vasculitis (GPA/MPA)

AutoBot / August 18, 2022
News Pharmacy

CSL Vifor’s Tavneos (avacopan) Receives NICE Recommendation for the Treatment of Anca-Associated Vasculitis (GPA/MPA)

AutoBot / August 18, 2022
News Pharmacy

Genentech Entered into an Exclusive WW License Agreement with Jemincare to Develop and Commercialize JMKX002992 for Prostate Cancer

AutoBot / August 18, 2022
News Pharmacy

CSL Vifor’s Tavneos (avacopan) Receives NICE Recommendation for the Treatment of Anca-Associated Vasculitis (GPA/MPA)

AutoBot / August 18, 2022
News Pharmacy

Blueprint Medicines Reports (PIONEER) Trial Results of Ayvakit (avapritinib) for the Treatment of Non-Advanced Systemic Mastocytosis

AutoBot / August 18, 2022
News Pharmacy

CSL Vifor plans UK launch after NICE backs rare disease drug Tavneos

AutoBot / August 18, 2022
News Pharmacy

Mepro Pharmaceuticals Pvt. Ltd- Openings for Regulatory Affairs/ Production-Apply Now

AutoBot / August 18, 2022
News Pharmacy

New drug application accepted by FDA for GSK’s momelotinib

AutoBot / August 18, 2022
News Pharmacy

Chiesi’s Trimbow recommended for use within NHS Scotland

AutoBot / August 18, 2022
News Pharmacy

Astellas files menopause drug fezolinetant in US, setting up Feb verdict

AutoBot / August 18, 2022
News Pharmacy

Frontiers Steering Committee spotlight: Megan Coder

AutoBot / August 18, 2022
News Pharmacy

Endo files for bankruptcy as it agrees opioid settlement

AutoBot / August 18, 2022
News Pharmacy

GSK Reports the US FDA’s Acceptance of NDA for Momelotinib to Treat Myelofibrosis

AutoBot / August 18, 2022
News Pharmacy

GSK Reports the US FDA’s Acceptance of NDA for Momelotinib to Treat Myelofibrosis

AutoBot / August 18, 2022
News Pharmacy

Bluebird unveils $2.8m price for gene therapy Zynteglo on FDA approval

AutoBot / August 18, 2022
News Pharmacy

bluebird bio’s Zynteglo (betibeglogene autotemcel) Receives the US FDA’s Approval for the Treatment of Beta-Thalassemia

AutoBot / August 18, 2022
News Pharmacy

bluebird bio’s Zynteglo (betibeglogene autotemcel) Receives the US FDA’s Approval for the Treatment of Beta-Thalassemia

AutoBot / August 18, 2022
News Pharmacy

Sanofi Entered into a Multi-Target Research Collaboration with Atomwise for AI-Powered Drug Discovery

AutoBot / August 18, 2022
News Pharmacy

Aurobindo Pharma-Walk-In Interviews for Research Associate -FRD On 21st Aug’ 2022

AutoBot / August 18, 2022

Copyright © 2022 | WordPress Theme by MH Themes

en English
af Afrikaanssq Shqipam አማርኛar العربيةhy Հայերենaz Azərbaycan dilieu Euskarabe Беларуская моваbn বাংলাbs Bosanskibg Българскиca Catalàceb Cebuanony Chichewazh-CN 简体中文zh-TW 繁體中文co Corsuhr Hrvatskics Čeština‎da Dansknl Nederlandsen Englisheo Esperantoet Eestitl Filipinofi Suomifr Françaisfy Fryskgl Galegoka ქართულიde Deutschel Ελληνικάgu ગુજરાતીht Kreyol ayisyenha Harshen Hausahaw Ōlelo Hawaiʻiiw עִבְרִיתhi हिन्दीhmn Hmonghu Magyaris Íslenskaig Igboid Bahasa Indonesiaga Gaeligeit Italianoja 日本語jw Basa Jawakn ಕನ್ನಡkk Қазақ тіліkm ភាសាខ្មែរko 한국어ku كوردی‎ky Кыргызчаlo ພາສາລາວla Latinlv Latviešu valodalt Lietuvių kalbalb Lëtzebuergeschmk Македонски јазикmg Malagasyms Bahasa Melayuml മലയാളംmt Maltesemi Te Reo Māorimr मराठीmn Монголmy ဗမာစာne नेपालीno Norsk bokmålps پښتوfa فارسیpl Polskipt Portuguêspa ਪੰਜਾਬੀro Românăru Русскийsm Samoangd Gàidhligsr Српски језикst Sesothosn Shonasd سنڌيsi සිංහලsk Slovenčinasl Slovenščinaso Afsoomaalies Españolsu Basa Sundasw Kiswahilisv Svenskatg Тоҷикӣta தமிழ்te తెలుగుth ไทยtr Türkçeuk Українськаur اردوuz O‘zbekchavi Tiếng Việtcy Cymraegxh isiXhosayi יידישyo Yorùbázu Zulu